Related references
Note: Only part of the references are listed.Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response
E. M. van Wezel et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
Daniel Todt et al.
ANTIVIRAL RESEARCH (2018)
Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse
Daniel Todt et al.
CURRENT OPINION IN VIROLOGY (2018)
Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes
Andre Mateus et al.
PROTEOME SCIENCE (2017)
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection
Marc van der Valk et al.
JOURNAL OF HEPATOLOGY (2017)
The HSP90 chaperone machinery
Florian H. Schopf et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Hepatitis E and pregnancy: current state
Maria Teresa Perez-Gracia et al.
REVIEWS IN MEDICAL VIROLOGY (2017)
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity
Yannick Debing et al.
JOURNAL OF HEPATOLOGY (2016)
Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat
Isabelle Becher et al.
NATURE CHEMICAL BIOLOGY (2016)
Hepatitis E virus ORF1 encoded non structural protein-host protein interaction network
Nishant Kumar Ojha et al.
VIRUS RESEARCH (2016)
Hepatitis E: Discovery, global impact, control and cure
Mohammad S. Khuroo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Expanding Host Range and Cross-Species Infection of Hepatitis E Virus
Xiang-Jin Meng
PLOS PATHOGENS (2016)
A Mutation in the Hepatitis E Virus RNA Polymerase Promotes Its Replication and Associates With Ribavirin Treatment Failure in Organ Transplant Recipients
Yannick Debing et al.
GASTROENTEROLOGY (2014)
Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
Nassim Kamar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential
Catherine Stedman
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2014)
The Therapeutic Target Hsp90 and Cancer Hallmarks
Yoshihiko Miyata et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Hepatitis E virus: the current scenario
Subrat Kumar et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
Broad action of Hsp90 as a host chaperone required for viral replication
Ron Geller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
The global burden of hepatitis E virus genotypes 1 and 2 in 2005
David B. Rein et al.
HEPATOLOGY (2012)
Hepatitis E virus replication involves alternating negative- and positive-sense RNA synthesis
Satya Pavan Kumar Varma et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant
Priyanka Shukla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Role of heat-shock protein 90 in hepatitis E virus capsid trafficking
Zi-Zheng Zheng et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Influence of Immunosuppressive Therapy on the Natural History of Genotype 3 Hepatitis-E Virus Infection After Organ Transplantation
Nassim Kamar et al.
TRANSPLANTATION (2010)
In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor
Tse-I Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors
Tzu-Yin Lin et al.
EXPERIMENTAL HEMATOLOGY (2008)
Cell Culture-Produced Hepatitis C Virus Does Not Infect Peripheral Blood Mononuclear Cells
Svedana Marukian et al.
HEPATOLOGY (2008)
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues
Swee Y. Sharp et al.
MOLECULAR CANCER THERAPEUTICS (2007)
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells
BA Malcolm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
Y Benhamou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
